Board of Trustees
Our Board of Trustees is responsible for the strategic management of the organisation and delivery of our charitable objectives.
Search
Search results
Medical Advisory Board
Our Medical Advisory Board (MAB) advises our Board of Trustees in order that they can approve grants for research projects.
Phase 3 clinical trial has been given approval by FDA
The FDA has given Ocugen permission to start their phase 3 gene therapy clinical trial for retinitis pigmentosa (RP).
Online information & support
Retina UK has a number of online support resources which we offer via social media.
Eye structure
The eye is a very complex organ. It has a lens at the front which focuses light on to a light sensitive tissue that lines the inside of the back of the eye – this tissue is called the retina.
Giving in memory
Celebrate the life of your loved one, by donating in their memory and help us fund more research and support, now.
Meet a researcher: Hassina Zeriri
It’s not very often that we come across a researcher working on a project inspired by their own lived experience of a sight loss condition.
Webinar: Career pathways for young people with sight loss
Join us for our upcoming webinar!
Optogenetics
The BBC covered a story on Monday 24 May about optogenetics partially restoring the sight of a man living with retinitis pigmentosa in France.